@protherics.com Pages on BioPortfolio:

BioPortfolio - Protherics - Profile
Protherics Announces Interim Results for Six Months Ended 30 September 2008 ... FDA Sends Letter to Protherics Over Voraxaze Web Material ...
http://www.bioportfolio.com/biocorporate/8617-Protherics.pdf...

BioPortfolio - protherics.co.uk
protherics.co.uk - BioPortfolio. ... Recent Search Terms used to find this page: protherics.co.uk | @protherics.com | Antibody production Polyclonal-derived ...
http://www.bioportfolio.com/search/protherics.co.uk.html...

BioPortfolio - protherics preeclampsia
protherics preeclampsia - BioPortfolio. ... BTG Takes Over Protherics in $397M Share Transaction . ...
http://www.bioportfolio.com/search/protherics_preeclampsia.h...

BTG plc (LSE: BGC): Interim Results for the Six Months Ended 30 ...
30 Sep 2008 ... Recommended all-share offer by BTG plc for Protherics PLC to be ... With a robust cash position and the merger with Protherics due to ...
http://www.bioportfolio.com/biotech_news/BTG_14.htm...

PriceWaterhouseCoopers BioScience Index and Share League March to ...
Protherics' Digitab trial results for use in oleander poisoning ... Protherics is to issue convertible unsecured debentures to raise £6.5m to fund ongoing ...
http://www.bioportfolio.com/pwc/coopers/APR2000.htm...

Eden Biopharma Group raises £5million in investment
More recently he was Chief Scientific Officer of Protherics plc and is now Non- Exec Director of that company and Chairman of a number of biotechnology ...
http://www.bioportfolio.com/news/Eden_Biopharm_1.htm...

BioPortfolio - Biocorporate Search
Protherics. We are a biopharmaceutical business, with approximately 125 employees and operations in the United ... www.protherics.co.uk/ View full
profile ...
http://www.bioportfolio.com/biocorporate/BioCorporate_Direct...

Results from other life science and pharmaceutical sites:

AstraZeneca and Protherics Announce Late Stage Licensing Agreement ...
8 Dec 2005 ... AstraZeneca Press Release: AstraZeneca and Protherics Announce Late Stage Licensing Agreement On CytoFab.
http://www.astrazeneca.com/pressrelease/5197.aspx...

News: Protherics PLC announces Regulatory Application. Genetic ...
Protherics PLC announces Regulatory Application. Genetic Engineering & Biotechnology News - Biotechnology from Bench to Business. The Leading
Publication in ...
http://www.genengnews.com/news/bnitem.aspx?name=45901963&tax...

News: Protherics PLC announces Delisting from NASDAQ. Genetic ...
14 Nov 2008 ... Protherics PLC announces Delisting from NASDAQ. Genetic Engineering & Biotechnology News - Biotechnology from Bench to Business.
http://www.genengnews.com/news/bnitem.aspx?name=45515177...

Protherics PLC And AstraZeneca PLC Updates CytoFab(TM) Development ...
Under the terms of the licensing agreement, AstraZeneca is responsible for conducting and funding the global development of CytoFab(TM) and Protherics is
...
http://www.biospace.com/news_story.aspx?NewsEntityId=35929...

Protherics - Stmnt re Share Price Movement: Financial News - Yahoo ...
Protherics - Stmnt re Share Price Movement. - Cheshire, UK--(MARKET WIRE)--Aug 13, 2008 -- Protherics PLC.
http://biz.yahoo.com/iw/080813/0424782.html...

Protherics PLC Start of Phase 2a Clinical Study of Angiotensin ...
The study will assess the safety and tolerability of the vaccine, incorporating Protherics’ promising novel vaccine adjuvant, CoVaccine HT™. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=101402...

Protherics Plc announces - Holding(s) in Company 2: Financial News ...
20 Nov 2008 ... Protherics Plc announces - Holding(s) in Company 2. - Cheshire, UK--(MARKET WIRE )--Nov 20, 2008 -- Protherics PLC Notification of Major ...
http://biz.yahoo.com/iw/081120/0454581.html...

MacroMed, Inc. Announces Acquisition By Protherics PLC For $25 ...
Protherics plans to continue MacroMed operations at the current West Valley City , Utah facility. The acquisition remains subject to the approval of the ...
http://www.biospace.com/news_story.aspx?NewsEntityId=39680...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.